Zoetis upgraded at Morgan Stanley As previously reported, Morgan Stanley upgraded Zoetis to Overweight from Equal Weight. The firm expects revenue growth to accelerate in 2014 based on easier comps and a livestock recovery. Price target is $36.
News For ZTS From The Last 14 Days
Check below for free stories on ZTS the last two weeks.
Piper Jaffray to hold a conference 25th Annual Healthcare Conference is being held in New York on December 3-4 with webcasted company presentations to begin on December 3 at 8 am; not all company presentations may be webcasted. Webcast Link
Sources: Novartis opens animal health books to Bayer, Reuters reports According to sources, Reuters reports that Novartis (NVS) has opened the books of its animal health business to Bayer (BAYRY) and other rivals. The suitors are currently conducting a due diligence assessment of the business. Reference Link